Cite
HARVARD Citation
Ma, Y. et al. (2018). Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis. Modern rheumatology. 28 (5), pp. 849-857. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, Y. et al. (2018). Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis. Modern rheumatology. 28 (5), pp. 849-857. [Online].